Breast cancer risk associated with multigenotypic polymorphisms in folate-metabolizing genes: A nested case-control study in Taiwan

Anticancer Research

Volumn 27, Issue 3 B, 2007, Pages 1727-1732

  Yu, Cheng Ping ^a   Wu, Mei Hsuan ^b   Chou, Yu Ching ^b   Yang, Tsan ^c   You, San Lin ^d   Chen, Chien Jen ^d   Sun, Chien An ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c MEIHO UNIVERSITY   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Breast cancer; Folate metabolism; Genetic susceptibility

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ESTROGEN; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE SYNTHASE;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ESTROGEN METABOLISM; FEMALE; FOLATE METABOLISM; GENOMIC INSTABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; TAIWAN;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PENETRANCE; POLYMORPHISM, GENETIC; TAIWAN;

EID: 34249276752     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stover PJ: Physiology of folate and vitamin B12 in health and disease. Nutr Rev 62: S3-S12, 2004.
2. Kim YI: Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 10: 66-88, 1999.
3. Herbig K, Chiang EP, Lee LR, Hills J, Shane B and Stover PJ: Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosynthesis. J Biol Chem 277: 38381-38389, 2002.
4. Stover PJ, Chen LH, Suh JR, Stover DM, Keyomarsi K and Shane B: Molecular cloning, characterization, and regulation of the human mitochondrial serine hydroxymethyltransferase gene. J Biol Chem 272: 1842-1848, 1997.
5. Girgis S, Nasrallah IM, Suh JR, Stover DM, Keyomarsi K and Shane B: Molecular cloning, characterization and alternative splicing of the human cytoplasmic serine hydroxymethyltransferase gene. Gene 210: 315-324, 1998.
6. Heil SG, Van der Put NM, Waas ET, den Heijer M, Trijbels FJ and Blom HJ: Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 73: 164-172, 2001.
7. Bailey LB and Gregory JF: Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 129: 919-922, 1999.
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP and Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10: 111-113, 1995.
9. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J and Shane B: Human methionine synthase: cDNA cloning, gene localization, and expression. J Biol Chem 272: 3628-3634, 1997.
10. Clemons M and Goss P: Estrogen and the risk of breast cancer. N Engl J Med 344: 276-285, 2001.
11. Yager JD: Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 27: 67-73, 2000.
12. Yager JD and Liehr JG: Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36: 203-232, 1996.
13. Cheng TC, Chen ST, Huang CS, Fu YP, Yu JC, Cheng CW, Wu PE and Shen CY: Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113: 345-353, 2005.
14. Lin WY, Chou YC, Wu MH, Huang HB, Jeng YL, Wu CC, Yu CP, Yu JC, You SL, Chu TY, Chen CJ and Sun CA: The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: a nested case-control study in Taiwan. Anticancer Res 24: 3863-3868, 2004.
15. Chen CJ, Lu SN, You SL, Wu MH, Wang LY, Lee LT, Huang GT, Yang PM and Lee HS: Community-based hepatocellular carcinoma screening in seven townships in Taiwan. J Formos Med Assoc 94(Suppl.2): S94-S102, 1995.
16. Chen CJ, You SL, Pwu RF, Wang LY, Lin YP, His CC, His MS, Ho HC, Lee CT, Lin CC, Ou YC, Yuan ML, Hsing AW, Huang TW and Hsieh CY: Community-based cervical cancer screening in seven townships in Taiwan. J Formos Med Assoc 94(Suppl.2): S103-S111, 1995.
17. Department of Health. Cancer Registry: Annual Report, 2000. Department of Health. Executive Yuan, Republic of China, 2003.
18. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR, Rollinson S, Roman E, Cartwright RA and Morgan GJ: Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99: 3786-3791, 2002.
19. Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter DJ, Chen J, Willett WC, Selhub J, Hennekens CH, Gravel R and Rozen R: A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocysteine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 8: 825-829, 1999.
20. Kim MJ, Cardiff RD, Desai N Banach-Petrosky WA, Parsons R, Shen MM and Abate-Shen C: Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 99: 2884-2889, 2002.
21. Perera FP, Mooney LA, Stampfer M, Phillips DH, Bell DA, Rundle A, Cho S, Tsai WY, Ma J, Blackwood A and Tang D: Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis 23: 1641-1646, 2002.
22. Colditz GA and Frazier AL: Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 4: 567-571, 1995.
23. Wu MH, Chou YC, Yu JC, Yu CP, Wu CC, Chu CM, Yang T, Lai CH, Hsieh CY, You SL, Chen CJ and Sun CA: Hormonal and body-size factors in relation to breast cancer risk: A prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 16: 223-229, 2006.
24. Wagner C: Biochemical role of folate in cellular metabolism. In: Folate in Health and Disease. Bailey LB (ed.). New York, Marcel Dekker, pp23-42, 1995.
25. Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, Chen ST, Wu HS, Wu PE and Shen CY: Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res 63: 2440-2446, 2003.
26. Nakachi K, Imai K, Hayashi S and Kawajiri K: Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53: 2994-2999, 1993.
27. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH and Rozen R: Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-1102, 1997.
28. Vairaktaris E, Yapijakis C, Kessler P, Vylliotis A, Ries J, Wiltfang J, Vassiliou S, Derka S and Neukam EW: Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 132: 219-222, 2006.
29. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, Jin F and Zheng W: MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 13: 190-196, 2004.
30. Shen YC, Chang CJ, Hsu C, Cheng CC, Chiu CF and Cheng AL: Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 14: 1986-1990, 2005.